(Q44396376)

English

Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients

scientific article published on 23 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients (English)

1 reference

Europe PubMed Central

2 December 2017

7

object named as

Klaus Friese

1 reference

Europe PubMed Central

2 December 2017

6

0 references

author name string

Christian Schindlbeck

1

1 reference

Europe PubMed Central

2 December 2017

Ulrich Andergassen

2

1 reference

Europe PubMed Central

2 December 2017

Simone Hofmann

3

1 reference

Europe PubMed Central

2 December 2017

Julia Jückstock

4

1 reference

Europe PubMed Central

2 December 2017

Udo Jeschke

5

1 reference

Europe PubMed Central

2 December 2017

Wolfgang Janni

8

1 reference

Europe PubMed Central

2 December 2017

Brigitte Rack

9

1 reference

Europe PubMed Central

2 December 2017

publication date

23 March 2013

1 reference

Europe PubMed Central

2 December 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

2 December 2017

139

1 reference

Europe PubMed Central

2 December 2017

6

1 reference

Europe PubMed Central

2 December 2017

1055-1062

1 reference

Europe PubMed Central

2 December 2017

https://scigraph.springernature.com/pub.10.1007/s00432-013-1418-0

0 references

A pooled analysis of bone marrow micrometastasis in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Circulating tumour cells in non-metastatic breast cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Biomarkers characterization of circulating tumour cells in breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Efficient capture of circulating tumor cells with a novel immunocytochemical microfluidic device

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

CTCs in primary breast cancer (I).

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Immunomagnetic enrichment and detection of isolated tumor cells in bone marrow of patients with epithelial malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

Cell filtration‐laser scanning cytometry for the characterisation of circulating breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1418-0

21 January 2018

The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/23525580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23525580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/23525580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/23525580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23525580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential pathological application of immunocytochemical methods to the detection of micrometastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/23525580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23525580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23525580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23525580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23525580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in patients with primary invasive ductal breast carcinoma - a 7.5-year follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23525580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23525580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/23525580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23525580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic relevance of disseminated tumor cells in the bone marrow of patients with primary breast cancer--results of a standardized follow-up.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23525580

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-013-1418-0

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44396376&oldid=2020970612"